These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 4999263)

  • 1. The use of human F(ab') 2 fragments as blocking agents in the mixed lymphocyte reaction.
    Hornung MO; Layne E; McDonald JC
    J Immunol; 1971 Oct; 107(4):979-84. PubMed ID: 4999263
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies and early human transplant rejection.
    De Planque BA; Williams GM; Borst-Eilers E; Hume D
    Transplant Proc; 1971 Mar; 3(1):376-9. PubMed ID: 4106325
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of mixed leukocyte culture reactivity by sera from hemodialysis patients and transplant recipients as an indicator of isoimmunization.
    Suciu-Foca N; Buda JA; Thiem T; Almojera P; Reemtsma KB
    Lab Invest; 1974 Jul; 31(1):1-5. PubMed ID: 4276465
    [No Abstract]   [Full Text] [Related]  

  • 4. The antigenic stimulus in human transplantation.
    Kahan BD; Mittal KK; Reisfeld RA; Terasaki PI; Bergan JJ
    Surgery; 1973 Jul; 74(1):153-62. PubMed ID: 4146045
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of lymphocyte proliferative responses by anti-HL-A alloantisera.
    Brochier J; Roitt IM; Festenstein H
    Eur J Immunol; 1974 Nov; 4(11):709-15. PubMed ID: 4279178
    [No Abstract]   [Full Text] [Related]  

  • 6. Blocking antibody in the sera and on the kidneys of successful human transplants.
    Hattler BG; Miller J
    Transplant Proc; 1973 Mar; 5(1):655-9. PubMed ID: 4266672
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of antibodies following human renal homograft rejection.
    Rolley RT; Williams GM; Lerner RA; Hanscom G; Hume DM
    Transplant Proc; 1969 Mar; 1(1):275-8. PubMed ID: 4944226
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of kidney allograft rejection.
    Najarian JS; Foker JE
    Transplant Proc; 1969 Mar; 1(1):184-93. PubMed ID: 4944216
    [No Abstract]   [Full Text] [Related]  

  • 9. The protective effect of F(ab') 2 and succinylated IgG in the early treatment of hyperacute rejection in the primate.
    Habal MB; Carpenter CB; Kobayashi K; Bush GJ; Misra M; Birtch AG
    Transplant Proc; 1973 Mar; 5(1):601-6. PubMed ID: 4633093
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional characterization of blocking antibody after human renal transplantation.
    Miller J; Lifton J; Rood F; Kyriakides G; Gajl-Peczalska KY; Yunis EJ; Hattler BG
    Surgery; 1974 Jul; 76(1):129-41. PubMed ID: 4135311
    [No Abstract]   [Full Text] [Related]  

  • 11. The significance of antivascular endothelium antibody in renal transplantation.
    Cerilli J; Jesseph JE; Miller AC
    Surg Gynecol Obstet; 1972 Aug; 135(2):246-52. PubMed ID: 4559046
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic enhancement induced by antibody fragments.
    Cruse JM; Forbes JT; Gillespie GY; Lewis GK
    Z Immunitatsforsch Allerg Klin Immunol; 1970; 140(3):259-67. PubMed ID: 4251393
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies with anti-lymphocytic antibody and antibody-fragments.
    James K
    Prog Immunobiol Stand; 1970; 4():256-64. PubMed ID: 4394821
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship of mixed lymphocyte culture response, HL-A histocompatibility antigens, and renal transplantation.
    Thompson JS; Flink RJ; Caldwell JL; Severson CD; Bonney WW
    Transplant Proc; 1973 Dec; 5(4):1763-9. PubMed ID: 4130081
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunological concepts relating to organ transplantation].
    Dei Poli G; Massa G; Rosso PA; Dei Poli N
    Minerva Chir; 1980 Jun; 35(11):829-78. PubMed ID: 6450338
    [No Abstract]   [Full Text] [Related]  

  • 16. Analyses of histocompatibility in cadaver renal transplantation.
    Morris PJ
    Transplant Proc; 1971 Jun; 3(2):1030-5. PubMed ID: 4944045
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibitory effect on lymphocyte transformation of anti-HL-A sera].
    Pospísil M; Meo T; Carbonara AO; Ceppellini R
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1970; 63(11):860-74. PubMed ID: 5524311
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship of the histocompatibility locus in the pig to allograft survival.
    White DJ; Bradley B; Calne RY; Binns RM
    Transplant Proc; 1973 Mar; 5(1):317-20. PubMed ID: 4266654
    [No Abstract]   [Full Text] [Related]  

  • 19. Active or passive enhancement and allograft survival.
    Wilson RE
    Transplant Proc; 1972 Dec; 4(4):513-5. PubMed ID: 4405144
    [No Abstract]   [Full Text] [Related]  

  • 20. Allogeneic marrow transplants in cyclophosphamide treated mice.
    Santos GW; Owens AH
    Transplant Proc; 1969 Mar; 1(1):44-6. PubMed ID: 4400067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.